This weight gain was associated with reversal of improvements in blood pressure, cholesterol, blood glucose and insulin sensitivity, reinforcing the need for continued treatment in adults living with obesity. Details from phase III of Novo Nordisks EVOKE trial, announced on 24 November 2025, found that glucagon-like peptide-1 receptor semaglutide had no effect on the progression of cognitive decline in people with Alzheimers disease, despite previous hopes that it could slow the disease
It is important to keep accidental sticks from happening to humans and animals
This is not an ad even though it sounds like it lol
Future priorities should include trials of GLP-1RA in non-diabetic patients with CKD, as well as further evaluation of dual or triple agonists (GLP-1/GIP/glucagon) and clarification of oral GLP1RA efficacy
Summary: Rybelsus is not formally associated with widespread skin sensitivity, though some patients may experience hypersensitivity reactions such as rash, itching, or urticaria